![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PFIZER NAMES JEFFREY KINDLER CEO
PFIZER NAMES JEFFREY KINDLER CEO
July 31, 2006
Pfizer Inc.'s board of directors named Jeffrey Kindler, the company's general counsel and vice chairman, to replace Hank McKinnell as chief executive, the drug maker said Friday evening. Kindler, 51, joined the company in 2002, and has been responsible for major corporate functions such as worldwide legal affairs,
corporate and regulatory compliance and government relations, Pfizer said in
a statement.
Market
Watch
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct